Venn Life Sciences was approached by a small biotech company to perform the noncompartmental pharmacokinetic analysis for one of their animal studies. Further to this they wanted to correlate exposure and other PK parameters with results of performed immunogenicity assays in the animals.

A small sized pharmaceutical company, who had already performed proof-of-concept studies with a small molecule drug candidate came to Venn Life Sciences with the aim to bring their product into clinic as soon as possible.